These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34619060)

  • 1. Characterization of
    Kiełpiński ŁJ; Funder ED; Schmidt S; Hagedorn PH
    Nucleic Acid Ther; 2021 Dec; 31(6):383-391. PubMed ID: 34619060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides.
    Østergaard ME; De Hoyos CL; Wan WB; Shen W; Low A; Berdeja A; Vasquez G; Murray S; Migawa MT; Liang XH; Swayze EE; Crooke ST; Seth PP
    Nucleic Acids Res; 2020 Feb; 48(4):1691-1700. PubMed ID: 31980820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAT10 and DDX21 Proteins Interact with RNase H1 and Affect the Performance of Phosphorothioate Oligonucleotides.
    Zhang L; Bernardo KD; Vickers TA; Tian J; Liang XH; Crooke ST
    Nucleic Acid Ther; 2022 Aug; 32(4):280-299. PubMed ID: 35852833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biophysical properties and biological activity of second generation antisense oligonucleotides containing chiral phosphorothioate linkages.
    Wan WB; Migawa MT; Vasquez G; Murray HM; Nichols JG; Gaus H; Berdeja A; Lee S; Hart CE; Lima WF; Swayze EE; Seth PP
    Nucleic Acids Res; 2014 Dec; 42(22):13456-68. PubMed ID: 25398895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides.
    Iwamoto N; Butler DCD; Svrzikapa N; Mohapatra S; Zlatev I; Sah DWY; Meena ; Standley SM; Lu G; Apponi LH; Frank-Kamenetsky M; Zhang JJ; Vargeese C; Verdine GL
    Nat Biotechnol; 2017 Sep; 35(9):845-851. PubMed ID: 28829437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteins.
    Zhang L; Vickers TA; Sun H; Liang XH; Crooke ST
    Nucleic Acids Res; 2021 Mar; 49(5):2721-2739. PubMed ID: 33577678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
    Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
    Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.
    Shen W; De Hoyos CL; Migawa MT; Vickers TA; Sun H; Low A; Bell TA; Rahdar M; Mukhopadhyay S; Hart CE; Bell M; Riney S; Murray SF; Greenlee S; Crooke RM; Liang XH; Seth PP; Crooke ST
    Nat Biotechnol; 2019 Jun; 37(6):640-650. PubMed ID: 31036929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How RNase HI (Escherichia coli) promoted site-selective hydrolysis works on RNA in duplex with carba-LNA and LNA substituted antisense strands in an antisense strategy context?
    Plashkevych O; Li Q; Chattopadhyaya J
    Mol Biosyst; 2017 May; 13(5):921-938. PubMed ID: 28352859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and subcellular analysis of PS-ASO/protein interactions with P54nrb and RNase H1.
    Vickers TA; Rahdar M; Prakash TP; Crooke ST
    Nucleic Acids Res; 2019 Nov; 47(20):10865-10880. PubMed ID: 31495875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of metal ions in the hydrolysis reaction catalyzed by RNase P RNA from Bacillus subtilis.
    Warnecke JM; Held R; Busch S; Hartmann RK
    J Mol Biol; 1999 Jul; 290(2):433-45. PubMed ID: 10390342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribonuclease P (RNase P) RNA is converted to a Cd(2+)-ribozyme by a single Rp-phosphorothioate modification in the precursor tRNA at the RNase P cleavage site.
    Warnecke JM; Fürste JP; Hardt WD; Erdmann VA; Hartmann RK
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):8924-8. PubMed ID: 8799129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA modifications can affect RNase H1-mediated PS-ASO activity.
    Doxtader Lacy KA; Liang XH; Zhang L; Crooke ST
    Mol Ther Nucleic Acids; 2022 Jun; 28():814-828. PubMed ID: 35664704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertion of a methylene group into the backbone of an antisense oligonucleotide reveals the importance of deoxyribose recognition by RNase H.
    Masaki Y; Tabira A; Hattori S; Wakatsuki S; Seio K
    Org Biomol Chem; 2022 Nov; 20(45):8917-8924. PubMed ID: 36321625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo properties of therapeutic oligonucleotides containing non-chiral 3' and 5' thiophosphate linkages.
    Duschmalé J; Hansen HF; Duschmalé M; Koller E; Albaek N; Møller MR; Jensen K; Koch T; Wengel J; Bleicher K
    Nucleic Acids Res; 2020 Jan; 48(1):63-74. PubMed ID: 31754711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of mixed-backbone oligonucleotides on target binding affinity and target cleaving specificity and selectivity by Escherichia coli RNase H.
    Shen LX; Kandimalla ER; Agrawal S
    Bioorg Med Chem; 1998 Oct; 6(10):1695-705. PubMed ID: 9839001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of cloned and expressed human RNase H1.
    Wu H; Lima WF; Crooke ST
    J Biol Chem; 1999 Oct; 274(40):28270-8. PubMed ID: 10497183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-Phase Synthesis of Boranophosphate/Phosphorothioate/Phosphate Chimeric Oligonucleotides and Their Potential as Antisense Oligonucleotides.
    Takahashi Y; Sato K; Wada T
    J Org Chem; 2022 Mar; 87(6):3895-3909. PubMed ID: 34908418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    Gao WY; Han FS; Storm C; Egan W; Cheng YC
    Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Golgi-58K can re-localize to late endosomes upon cellular uptake of PS-ASOs and facilitates endosomal release of ASOs.
    Liang XH; Nichols JG; De Hoyos CL; Sun H; Zhang L; Crooke ST
    Nucleic Acids Res; 2021 Aug; 49(14):8277-8293. PubMed ID: 34244781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.